SCHEMBL6429786

SCHEMBL6429786

Cc1cc(C)nc(C#Cc2ccccc2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 13/20 0.62
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
KDM4E B2RXH2 1/20 0.53
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
TP53 P04637 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
PKM P14618 1/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 1/20 0.53
CYP2C19 P33261 1/20 0.53
THPO P40225 1/20 0.53
KMT2A Q03164 1/20 0.53
GRIN2B Q13224 1/20 0.53
GRM1 Q13255 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7385715 0.98 GRM5 (0.61) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL7389576 0.89 GRM5 (0.67) GRM5NPC1RAB9ASMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL7418874 0.87 GRM5 (0.65) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL13377842 0.83 GRM5 (0.57) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL596744 0.75 APP (0.50) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL4858200 0.75 PDGFRB (0.46) GRM5NPC1RAB9ASMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL4864461 0.73 PDGFRB (0.45) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL10277252 0.72 APP (0.52) GRM5NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL15947628 0.72 CYP1A2 (0.55) GRM5NPC1RAB9ASMN1; SMN2KDM4E
Diphenylacetylene SCHEMBL29188592 0.71 APP (1.00) GRM5NPC1RAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599204-A2 SELECTIVE MGLU5 ANTAGONISTS FOR TREATMENT OF NEUROMUSCULAR DYSFUNCTION OF THE LOWER URINARY TRACT Recordati Ireland Limited (IE) 2005-11-30 EP disclosed
US-20040215284-A1 Treatment of neuromuscular dysfunction of the lower urinary tract with selective mGlu5 antagonists RECORDATI S.A. 2004-10-28 US disclosed
WO-2004067002-A2 SELECTIVE mGlu5 ANTAGONISTS FOR TREATMENT OF NEUROMUSCULAR DYSFUNCTION OF THE LOWER URINARY TRACT RECORDATI IRELAND LIMITED (IE) 2004-08-12 WO disclosed